CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...
Share on PinterestNew research suggests that there may be more than 10.5 million people in the United States living with ...
In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...
The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
The study, led by New York University Langone Health researchers who looked at data from more than 6,000 Fitbit users who ...
OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...
New research indicates that 1 hour of moderate exercise per week can help prevent atrial fibrillation (AFib). While a small ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...
Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...
However, some research has found a link between high doses of fish oil and an increased risk of atrial fibrillation (Afib). Scientists are still studying the link between fish oil and Afib and do ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback